Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,515
Closed -$2.82M 38
2024
Q3
$2.82M Sell
12,515
-128,393
-91% -$29.8M 0.21% 31
2024
Q2
$31.7M Buy
140,908
+52,662
+60% +$12.2M 2.28% 20
2024
Q1
$21.4M Sell
88,246
-41,603
-32% -$9.56M 2.42% 20
2023
Q4
$26.7M Sell
129,849
-33,290
-20% -$6.5M 3.21% 17
2023
Q3
$29.4M Sell
163,139
-35,341
-18% -$6.53M 3.95% 14
2023
Q2
$38.2M Sell
198,480
-64,401
-24% -$11.1M 5.07% 6
2023
Q1
$42.1M Buy
262,881
+125,465
+91% +$19.9M 5.25% 3
2022
Q4
$22.8M Buy
137,416
+24,850
+22% +$3.93M 3.35% 16
2022
Q3
$15.2M Buy
112,566
+75
+0.1% +$10.8K 2.79% 20
2022
Q2
$15.9M Sell
112,491
-46,421
-29% -$7.1M 3.01% 18
2022
Q1
$24.6M Sell
158,912
-104,991
-40% -$14.9M 4.21% 14
2021
Q4
$35.1M Buy
263,903
+132,554
+101% +$16.3M 5.45% 5
2021
Q3
$15.7M Sell
131,349
-15,298
-10% -$1.84M 2.67% 20
2021
Q2
$16.8M Sell
146,647
-49,302
-25% -$5.82M 2.78% 20
2021
Q1
$23.1M Sell
195,949
-59,896
-23% -$6.48M 4.07% 14
2020
Q4
$25M Buy
255,845
+41,782
+20% +$4.18M 5.36% 6
2020
Q3
$20.7M Buy
214,063
+38,853
+22% +$3.86M 5.14% 3
2020
Q2
$17.7M Buy
+175,210
New +$16.1M 4.68% 4

Other funds holding COR

M.D. Sass LLC's COR Position: Q4 2024 in Review

M.D. Sass LLC sold out of Cencora (COR) in Q4 2024, closing a stake of 12,515 shares — an estimated $2.82M sold.

M.D. Sass LLC first reported a position in COR in Q2 2020 and held it in 18 quarters. The position peaked at $42.1M in Q1 2023. 1,227 funds tracked by Wall St. Rank hold COR as of Q4 2024.

  • M.D. Sass LLC reported no remaining Cencora position as of Q4 2024 after selling out during the quarter.
  • M.D. Sass LLC sold 12,515 Cencora shares in Q4 2024, an estimated $2.82M.
  • M.D. Sass LLC first reported a position in Cencora in Q2 2020 and held it in 18 quarters.
  • M.D. Sass LLC's Cencora position peaked at $42.1M in Q1 2023.
  • 1,227 funds tracked by Wall St. Rank held Cencora as of Q4 2024.

Based on M.D. Sass LLC's 13F filing for Q4 2024, filed 11 Feb 2025.